{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-158321","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.591309+00:00","generated_at":"2026-06-01T05:22:24.944530+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Ikena Oncology shareholders elect directors and ratify auditor at 2024 annual meeting","bullets":["Owen Hughes elected as Class III director with 22,250,184 votes for, 4,967,774 withheld.","Mark Manfredi elected as Class III director with 24,738,833 votes for, 2,479,125 withheld.","Ernst & Young ratified as auditor for FY2024 with 34,421,661 for, 31,819 against, 11,827 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-158321","json":"https://secwatch.observer/filing/0001193125-24-158321.json","markdown":"https://secwatch.observer/filing/0001193125-24-158321.md","text":"https://secwatch.observer/filing/0001193125-24-158321.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312524158321/0001193125-24-158321-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312524158321/d837508d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:22:24.944530+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}